In summary, we have demonstrated in both in vitro cell cultures and in vivo tumor models of HNSCC that mutant p53s can acquire GOF properties through a transcription independent mechanism promoting FOXM1 expression through inhibition of AMPK-mediated FOXO3a activation. The gene discussed is FOXM1; the disease is head and neck squamous cell carcinoma.